SEARCH

PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Showing posts with label purdue pharma. Show all posts
Showing posts with label purdue pharma. Show all posts

Thursday, May 6, 2010

purdue pharma,

REVERSED 
2100 Computer Architecture and Software 
Ex Parte Marcjan et al 10/403,063 COURTENAY 103(a) LEE & HAYES, PLLC EXAMINER LE, MICHAEL 

AFFIRMED-IN-PART 
1600 Biotechnology and Organic Chemistry 
Ex Parte Lee 10/928,806 SCHEINER 112(1)/112(2)/103(a) FISH & RICHARDSON, PC EXAMINER WHITEMAN, BRIAN A 

"In order to satisfy the written description requirement, the disclosure as originally filed does not have to provide in haec verba support for the claimed subject matter at issue." Purdue Pharma L.P. v. Faulding Inc., 230 F.3d 1320, 1323 (Fed. Cir. 2000). However, the disclosure must convey with reasonable clarity to those skilled in the art that the inventor was in possession of the invention. See id. 

Purdue Pharma L.P. v. Faulding, Inc., 230 F.3d 1320, 56 USPQ2d 1481 (Fed. Cir. 2000) . . . . . . . . . . . . . . . .2163, 2163.05